Stock Track | Damora Therapeutics Soars 7.88% Intraday on Leadership Shakeup with New CEO and Board Appointments

Stock Track

Yesterday

Damora Therapeutics (DMRA) saw its stock price soar 7.88% during intraday trading on Monday, following a significant announcement regarding its executive leadership and board composition.

The biotechnology company announced the appointment of Jennifer Jarrett as its new President and Chief Executive Officer, effective March 30, 2026. Jarrett brings nearly three decades of executive experience in biotech, technology, and finance, most recently serving as Chief Operating Officer of Arcus Biosciences. Her background includes leadership roles at Uber Technologies, serving as CFO of Medivation, and two decades in investment banking, positioning her to guide Damora's strategic development.

Concurrently, Damora strengthened its Board of Directors by adding Cameron Turtle, CEO of Spyre Therapeutics, and Mike Landsittel, former CFO of Blueprint Medicines. Peter Harwin was named Chairman of the Board. Investors reacted positively to this leadership refresh, viewing the infusion of seasoned biotech executives as a catalyst to accelerate the development of Damora's lead program, DMR-001, and advance its pipeline of therapies for blood disorders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1129559742"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129559742\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129559742?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-23 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129559742","market":"us","top_or_hot":-1,"title":"Stock Track | Damora Therapeutics Soars 7.88% Intraday on Leadership Shakeup with New CEO and Board Appointments","media":"Stock Track","content":"<p>Damora Therapeutics (DMRA) saw its stock price soar 7.88% during intraday trading on Monday, following a significant announcement regarding its executive leadership and board composition.</p><p>The biotechnology company announced the appointment of Jennifer Jarrett as its new President and Chief Executive Officer, effective March 30, 2026. Jarrett brings nearly three decades of executive experience in biotech, technology, and finance, most recently serving as Chief Operating Officer of Arcus Biosciences. Her background includes leadership roles at Uber Technologies, serving as CFO of Medivation, and two decades in investment banking, positioning her to guide Damora's strategic development.</p><p>Concurrently, Damora strengthened its Board of Directors by adding Cameron Turtle, CEO of Spyre Therapeutics, and Mike Landsittel, former CFO of Blueprint Medicines. Peter Harwin was named Chairman of the Board. Investors reacted positively to this leadership refresh, viewing the infusion of seasoned biotech executives as a catalyst to accelerate the development of Damora's lead program, DMR-001, and advance its pipeline of therapies for blood disorders.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Damora Therapeutics Soars 7.88% Intraday on Leadership Shakeup with New CEO and Board Appointments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Damora Therapeutics Soars 7.88% Intraday on Leadership Shakeup with New CEO and Board Appointments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-23 21:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Damora Therapeutics (DMRA) saw its stock price soar 7.88% during intraday trading on Monday, following a significant announcement regarding its executive leadership and board composition.</p><p>The biotechnology company announced the appointment of Jennifer Jarrett as its new President and Chief Executive Officer, effective March 30, 2026. Jarrett brings nearly three decades of executive experience in biotech, technology, and finance, most recently serving as Chief Operating Officer of Arcus Biosciences. Her background includes leadership roles at Uber Technologies, serving as CFO of Medivation, and two decades in investment banking, positioning her to guide Damora's strategic development.</p><p>Concurrently, Damora strengthened its Board of Directors by adding Cameron Turtle, CEO of Spyre Therapeutics, and Mike Landsittel, former CFO of Blueprint Medicines. Peter Harwin was named Chairman of the Board. Investors reacted positively to this leadership refresh, viewing the infusion of seasoned biotech executives as a catalyst to accelerate the development of Damora's lead program, DMR-001, and advance its pipeline of therapies for blood disorders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DMRA","symbol_name":"DAMORA THERAPEUT","start_time":0,"source_url":"","article_id":"1129559742","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129559742","pubTimestamp":1774273476,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Damora Therapeutics (DMRA) saw its stock price soar 7.88% during intraday trading on Monday, following a significant announcement regarding its executive leadership and board composition.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DMRA":"DAMORA THERAPEUT"},"translate_title":"个股追踪|Damora Therapeutics因领导层改组任命新CEO和董事会而盘中飙升7.88%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DMRA":1},"content_text":"Damora Therapeutics (DMRA) saw its stock price soar 7.88% during intraday trading on Monday, following a significant announcement regarding its executive leadership and board composition.The biotechnology company announced the appointment of Jennifer Jarrett as its new President and Chief Executive Officer, effective March 30, 2026. Jarrett brings nearly three decades of executive experience in biotech, technology, and finance, most recently serving as Chief Operating Officer of Arcus Biosciences. Her background includes leadership roles at Uber Technologies, serving as CFO of Medivation, and two decades in investment banking, positioning her to guide Damora's strategic development.Concurrently, Damora strengthened its Board of Directors by adding Cameron Turtle, CEO of Spyre Therapeutics, and Mike Landsittel, former CFO of Blueprint Medicines. Peter Harwin was named Chairman of the Board. Investors reacted positively to this leadership refresh, viewing the infusion of seasoned biotech executives as a catalyst to accelerate the development of Damora's lead program, DMR-001, and advance its pipeline of therapies for blood disorders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}